Highlights Melodiol Global Health Limited

Equities

ME1

AU0000282840

Market Closed - Australian S.E. Other stock markets 09:23:41 2024-05-13 pm EDT			5-day change	1st Jan Change
0.0025 ^AUD	-16.67%		+25.00%	-93.75%

May. 09	Melodiol Global's Mernova Unit Launches More Products; Shares Jump 50%	MT
Apr. 16	Melodiol Global's Revenue Surges 79% in Q1	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Melodiol Global's Mernova Unit Launches More Products; Shares Jump 50%	May. 09	MT
Melodiol Global's Revenue Surges 79% in Q1	Apr. 15	MT
Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic	Apr. 08	MT
Melodiol Global Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Melodial's Unit Logs AU$1 Million Revenues in January	Feb. 07	MT
Melodiol Global's Canadian Arm Mernova Posts Record Sales for October	Nov. 02	MT
Melodial's Canadian Arm Mernova Logs Record Sales in Q3	23-10-10	MT
Melodiol Global Health Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	23-08-01	CI
Melodiol Logs Strong Start to Q3 with AU$1.6 Million in Revenue and Confirmed Purchase Orders	23-07-20	MT
Creso Pharma Signs Deal to Import Psychedelic Medication into Australia	23-06-09	MT
Creso Pharma's Subsidiary Hires Consultant to Support Licensing Process in Australia, Europe	23-06-04	MT
Health House International to be Removed from Australian Bourse's Official List	23-05-17	MT
Creso Pharma Limited completed the acquisition of Health House International Limited.	23-05-15	CI
Creso Pharma Expands Pet Care Range to Asia with Distribution Deals	23-05-15	MT
Melodiol Global Health Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-28	CI
Creso Pharma Unit to Enter Australian Market After Approval of Psychedelics for Medical Use; Shares Fall 5%	23-02-06	MT
Creso Pharma Limited entered into a binding letter of intent to acquire Abby & Finn, LLC for $2.5 million.	23-01-26	CI
Creso Pharma Wins Seven New Product Listings in Canada	23-01-10	MT
Creso Pharma Completes Anibidiol Product Registration in South Korea; Shares Plunge 11%	22-11-22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Melodiol Global Health Limited

Equities

ME1

AU0000282840

Highlights

Filters